Dr Wen Qi Ho

Dr Wen Qi Ho

Dr Ho focuses on investing in and building global healthcare companies from Singapore. Prior to joining ClavystBio, she headed up the Singapore investments and operations for Lightstone Ventures, where she played a major role in establishing the firm’s presence in Singapore. Wen Qi evaluated new investment opportunities in the biopharmaceutical and medical device sectors and was actively involved in venture-building, working closely with companies in their development journey.

Dr Ho is a strong advocate for early-career researcher participation in biotech entrepreneurship and serves on advisory and grant review panels with leading institutions in Singapore. She also serves on the Board of Directors of Automera, Engine Biosciences and MediSix Therapeutics, as well as on the steering committee of 65LAB.

Dr Ho holds a PhD in Immunology from Stanford University and a BSc in Molecular and Cellular Biology from Johns Hopkins University.